Loading data
PYPDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 23.81 m USD | 22.81 m USD | 16.15 m USD | 27.99 m USD | 30.55 m USD |
| Operating profit | -32.97 m USD | -28.03 m USD | -22.87 m USD | -38.89 m USD | -43.15 m USD |
| Profit before tax | -34.16 m USD | -28.98 m USD | -23.8 m USD | -39.43 m USD | -42.6 m USD |
| Income tax expense | 5 k USD | 42 k USD | 69 k USD | 129 k USD | — |
| Net income (reported basis) | -34.17 m USD | -29.02 m USD | -23.87 m USD | -39.56 m USD | -42.6 m USD |
| Net income attributable to common shareholders | — | — | — | 39.56 m USD | 42.6 m USD |
| Basic earnings per share | 2.09 USD/share | 4.91 USD/share | 16.99 USD/share | 61.09 USD/share | 68.27 USD/share |
| Diluted earnings per share | 2.09 USD/share | 4.91 USD/share | 16.93 USD/share | 61.09 USD/share | 68.27 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.